Longitudinal Prediction of Ventricular Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy

被引:19
作者
Carrick, Richard T. [1 ]
te Riele, Anneline S. J. M. [2 ,3 ]
Gasperetti, Alessio [1 ,2 ]
Bosman, Laurens [2 ]
Muller, Steven A. [2 ]
Pendleton, Catherine [1 ]
Tichnell, Crystal [1 ]
Murray, Brittney [1 ]
Yap, Sing-Chien [3 ,4 ]
van den Berg, Maarten P. [5 ]
Wilde, Arthur [4 ,6 ]
Zeppenfeld, Katja [7 ]
Hays, Allison [1 ]
Zimmerman, Stefan L. [1 ]
Tandri, Harikrishna [1 ]
Cadrin-Tourigny, Julia [8 ]
van Tintelen, Peter [4 ,9 ]
Calkins, Hugh [1 ]
James, Cynthia A. [1 ]
Wu, Katherine C. [1 ]
机构
[1] Johns Hopkins Med Inst, Div Cardiol, Baltimore, MD 21287 USA
[2] Univ Med Ctr Utrecht, Dept Heart & Lungs, Div Cardiol, Utrecht, Netherlands
[3] Low Prevalence & Complex Dis Heart ERN Guard Hear, European Network Rare, Utrecht, Netherlands
[4] Univ Med Ctr Rotterdam, Rotterdam, Netherlands
[5] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[6] Univ Amsterdam, Med Ctr, Heart Failure & Arrhythmias, Amsterdam Cardiovasc Sci, Amsterdam, Netherlands
[7] Leiden Univ, Heart Ctr Leiden, Leiden, Netherlands
[8] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada
[9] Univ Med Ctr Utrecht, Dept Clin Genet, Utrecht, Netherlands
基金
美国国家卫生研究院;
关键词
cardiomyopathy; death; sudden; cardiac; defibrillator; implantable; risk factors; tachycardia; SUDDEN-DEATH; ANTIARRHYTHMIC-DRUGS; TIME; ASSOCIATION; PROGRESSION; DIAGNOSIS; EFFICACY; THERAPY; DISEASE; EVENTS;
D O I
10.1161/CIRCEP.122.011207
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The arrhythmogenic right ventricular cardiomyopathy (ARVC) risk calculator stratifies risk for incident sustained ventricular arrhythmias (VA) at the time of ARVC diagnosis. However, included risk factors change over time, and how well the ARVC risk calculator performs at follow-up is unknown. METHODS: This was a retrospective analysis of patients with definite ARVC and without prior sustained VA. Risk factors for VA including age, nonsustained ventricular tachycardia, premature ventricular complex burden, T-wave inversions on electrocardiogram, cardiac syncope, right ventricular function, therapeutic medication use, and exercise intensity were assessed at the time of 2010 Task Force Criteria based ARVC diagnosis and upon repeat evaluations. Changes in these risk factors were analyzed over 5-year follow-up. The 5-year risk of VA was predicted longitudinally using (1) the baseline ARVC risk calculator prediction, (2) the ARVC risk prediction calculated using updated risk factors, and (3) time-varying Cox regression. Discrimination and calibration were assessed in comparison to observed VA event rates. RESULTS: Four hundred eight patients with ARVC experiencing 132 primary VA events were included. Matched comparison of risk factors at baseline versus at 5 years of follow-up revealed decreased burdens of premature ventricular complexes (-1200/day) and nonsustained ventricular tachycardia (-14%). Presence of significant right ventricular dysfunction and number of T-wave inversions on electrocardiogram were unchanged. Observed risk for VA decreased by 13% by 5 years follow-up. The baseline ARVC risk calculator's ability to predict 5-year VA risk worsened during follow-up (C statistics, 0.83 at diagnosis versus 0.68 at 5 years). Both the updated ARVC risk calculator (C statistics of 0.77) and time-varying Cox regression model (C statistics, 0.77) had strong discrimination. The updated ARVC risk calculator overestimated 5-year VA risk by an average of +6%. CONCLUSIONS: Risk factors for VA in ARVC are dynamic, and overall risk for incident sustained VA decreases during follow-up. Up-to-date risk factor assessment improves VA risk stratification. [GRAPHICS] .
引用
收藏
页码:728 / 739
页数:12
相关论文
共 50 条
  • [31] Evolution and triggers of defibrillator shocks in patients with arrhythmogenic right ventricular cardiomyopathy
    Molitor, Nadine
    Hofer, Daniel
    cimen, Tolga
    Gasperetti, Alessio
    Akdis, Deniz
    Costa, Sarah
    Jenni, Rolf
    Breitenstein, Alexander
    Wolber, Thomas
    Winnik, Stephan
    Fokstuen, Siv
    Fu, Guan
    Medeiros-Domingo, Argelia
    Ruschitzka, Frank
    Brunckhorst, Corinna
    Duru, Firat
    Saguner, Ardan M.
    HEART, 2023, 109 (15) : 1146 - 1152
  • [32] Clinical Characteristics of Patients with a Right Ventricular Thrombus in Arrhythmogenic Right Ventricular Cardiomyopathy
    Akdis, Deniz
    Chen, Kai
    Saguner, Ardan M.
    Stampfli, Simon F.
    Chen, Xiao
    Chen, Liang
    Rao, Man
    Haegeli, Laurent M.
    Tanner, Felix C.
    Brunckhorst, Corinna
    Song, Jiangping
    Duru, Firat
    THROMBOSIS AND HAEMOSTASIS, 2019, 119 (08) : 1373 - 1378
  • [33] Integrating Exercise Into Personalized Ventricular Arrhythmia Risk Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy
    Bosman, Laurens P.
    Wang, Weijia
    Lie, Oyvind H.
    van Lint, Freyja H. M.
    Rootwelt-Norberg, Christine
    Murray, Brittney
    Tichnell, Crystal
    Cadrin-Tourigny, Julia
    van Tintelen, J. Peter
    Asselbergs, Folkert W.
    Calkins, Hugh
    te Riele, Anneline S. J. M.
    Haugaa, Kristina H.
    James, Cynthia A.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2022, 15 (02) : 85 - 93
  • [34] Association of Heart Rate Variability With Arrhythmic Events in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
    Battipaglia, Irma
    Scalone, Giancarla
    Macchione, Andrea
    Pinnacchio, Gaetano
    Laurito, Marianna
    Milo, Maria
    Pelargonio, Gemma
    Bencardino, Gianluigi
    Bellocci, Fulvio
    Pieroni, Maurizio
    Lanza, Gaetano A.
    Crea, Filippo
    CIRCULATION JOURNAL, 2012, 76 (03) : 618 - 623
  • [35] Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy A Family Affair
    Judge, Daniel P.
    CIRCULATION, 2011, 123 (23) : 2661 - 2663
  • [36] Catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia
    Arruda, Mauricio
    Armaganijan, Luciana
    Fahmy, Tamer
    Di Biase, Luigi
    Patel, Dimpi
    Natale, Andrea
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2009, 25 (02) : 129 - 133
  • [37] Guidelines for the Diagnosis and Management of Arrhythmogenic Right Ventricular Cardiomyopathy
    Smith, Warren
    HEART LUNG AND CIRCULATION, 2011, 20 (12) : 757 - 760
  • [38] Radiofrequency Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
    Romero, Jorge
    Grushko, Michael
    Briceno, David F.
    Natale, Andrea
    Di Biase, Luigi
    CURRENT CARDIOLOGY REPORTS, 2017, 19 (09)
  • [39] Clinical Management of Arrhythmogenic Right Ventricular Cardiomyopathy: An Update
    Migliore, Federico
    Zorzi, Alessandro
    Silvano, Maria
    Rigato, Ilaria
    Basso, Cristina
    Thiene, Gaetano
    Corrado, Domenico
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (26) : 2918 - 2928
  • [40] Dynamic electrocardiographic changes in patients with arrhythmogenic right ventricular cardiomyopathy
    Quarta, Giovanni
    Ward, Deirdre
    Esteban, Maria T. Tome
    Pantazis, Antonios
    Elliott, Perry M.
    Volpe, Massimo
    Autore, Camillo
    McKenna, William J.
    HEART, 2010, 96 (07) : 516 - 522